Hannelore G. Denys
Gent, VLG 9000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 115 publications
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study.
Journal: Gynecologic oncology
Published: February 02, 2026
Circulating immune cell profiling in advanced cervical and endometrial cancer patients treated with PD-1 blockade, radiotherapy, and immune modulation in the PRIMMO trial.
Journal: Frontiers in immunology
Published: January 22, 2026
Quality of Life Measures in Advanced Endometrial Cancer: A Systematic Review of Reporting Practices in Phase III Clinical Trials.
Journal: Cancers
Published: December 11, 2025
Increased hospital case volume is associated with improved survival and quality of care for uterine corpus cancer in Belgium.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 22, 2025
The Use of Tele-Music Interventions in Supportive Cancer Care: A Systematic Review.
Journal: Brain sciences
Published: October 24, 2025
A One-Step Workflow for Size-Based Separation of Extracellular Vesicles With Integrated Surface Marker Detection.
Journal: Journal of extracellular biology
Published: August 27, 2025
Uterine leiomyosarcoma.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 09, 2025
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
Journal: Cancer immunology, immunotherapy : CII
Published: December 31, 2024
Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial.
Journal: Gynecologic oncology
Published: December 23, 2024
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study.
Journal: Journal for immunotherapy of cancer
Published: December 23, 2024
Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 18, 2024
Last Updated: 09/26/2026